NJ Top Docs 2022, Dr, Brian Mehling and Dr. Pavel Yufit Specialize in Trauma Treatment
NJ Top Docs has reviewed and approved board-certified orthopedic surgeons, Brian Mehling, MD and Pavel Yufit, MD of Mehling Orthopedics for 2022. Both are fellows of the American Academy of Orthopedic Surgeons and specialize in trauma treatment. They are also members of the Orthopaedic Trauma Association. Their practice, Mehling Orthopedics is an orthopedic trauma practice dedicated to creating individualized treatment plans for traumatic injuries and disabilities. Dr. Mehling started his path in medicine through undergraduate study at Harvard University, obtaining his Bachelor of Arts...
Read MoreWORLD-RENOWNED STEM CELL RESEARCHER, BRIAN MEHLING, MD, SET TO ATTEND THE ANNUAL WORLD ECONOMIC FORUM IN DAVOS
ZURICH, Switzerland – May 4, 2022 – Brian Mehling, MD, a world-renowned stem cell researcher, board-certified orthopedic trauma surgeon, board-certified in anti-aging medicine, and founder of Blue Horizon International (BHI), will be attending the Annual World Economic Forum (WEF) in Davos from May 22-26. This will be Dr. Mehling’s ninth year attending the global conference. The 52nd Annual Meeting will convene on the theme “Working Together, Restoring Trust,” with the aim to address economic, environmental, political and social fault-lines exacerbated by the COVID-19...
Read MoreBlue Horizon International and Mehling Orthopedics to exhibit at American Academy Of Orthopaedic Surgeons Annual Meeting in Chicago
Brian Mehling, M.D. and Pavel Yufit, M.D., orthopedic surgeons with practices in New York and New Jersey, are scheduled to attend the 2022 Annual Meeting of the American Academy of Orthopaedic Surgeons in Chicago, Illinois from March 22-26, 2022 at the McCormick Place Convention Center. The booth number is 1904. This is the world’s largest meeting of orthopaedic surgeons, researchers, and allied health professionals. The meeting offers physicians the opportunity to exchange ideas with their colleagues and learn about cutting-edge technology in their field. Dr. Mehling is also...
Read MoreBrian Mehling, MD slated to participate in the 19th Annual World Congress of Society for Brain Mapping and Therapeutics
Breaking Boundaries of Science, Technology, Medicine, Art, and Healthcare Policy meeting being held in LA March 10-13 Brian Mehling, MD, founder and chief medical officer of BHI Therapeutic Sciences, will virtually present on three topics at the 19th Annual World Congress of Society for Brain Mapping and Therapeutics. The meeting, entitled Breaking Boundaries of Science, Technology, Medicine, Art, and Healthcare Policy, will be held at the Los Angeles Convention Center, March 10-13. Dr. Mehling will speak on the following: Safety study of Cultured Wharton’s Jelly Mesenchymal Stem...
Read MoreBHI CEO Participates in Patient Safety Workshop Sponsored by the Joint Commission
Doreen Santora, RN, MHA Doreen Santora, RN, MHA, chief executive officer of Blue Horizon International (BHI) and its subsidiaries, including BHI Therapeutic Sciences, recently participated the Joint Commission International (JCI) program titled Managing Patient Safety Events: A Root Cause Analysis Workshop. The two-day, live virtual workshop provided participants with the knowledge, skills, and strategies to establish a standardized approach to managing patient safety events, including sentinel events. “BHI Therapeutic Sciences is committed to providing the highest quality and...
Read More
